More Discussions on Impacts of Celltrion's KOSPI200 Inclusion
Celltrion Inc (068270 KS)Â said in a regulatory filing that it will have EGM at 10 AM on Aug 29 to decide whether it will move to KOSPI. Below is...
633 Views
Eubiologics IPO Part 3 - IPO Bookbuilding Results & Personal View
Eubiologics IPO price was set at ₩6,000, the lowest end of the indicative price band, after conducting the demand survey (bookbuilding) (Jan 9-10)...
582 Views
Eubiologics IPO Part 2 - Growth Potential & Appropriate Valuation Level
*Â In Part 2 (as below), I examined the company's business fundamentals in more detail along with its growth potential and appropriate valuation...
324 Views
Eubiologics IPO Part 1 - Schedule, Financials & Valuation
Eubiologics is a very "young" vaccine company that develops an oral cholera vaccine product called "Euvichol". This company will be Korea's first...
487 Views
MediSetter Interview:Â Insight on Opportunities in Asia's Healthcare Industry
Introduction to MedisetterI had the pleasure of interviewing Anirban Lahiri of Medisetter to discuss some of the opportunities present in Asia's...
4.1k Views